ATE290397T1 - Formulierung fur die wundheilung mit menschlichem plasma fibronektin - Google Patents
Formulierung fur die wundheilung mit menschlichem plasma fibronektinInfo
- Publication number
- ATE290397T1 ATE290397T1 AT96917308T AT96917308T ATE290397T1 AT E290397 T1 ATE290397 T1 AT E290397T1 AT 96917308 T AT96917308 T AT 96917308T AT 96917308 T AT96917308 T AT 96917308T AT E290397 T1 ATE290397 T1 AT E290397T1
- Authority
- AT
- Austria
- Prior art keywords
- human plasma
- fibronectin
- wound healing
- formulation
- plasma fibronectin
- Prior art date
Links
- 102000016359 Fibronectins Human genes 0.000 title abstract 4
- 108010067306 Fibronectins Proteins 0.000 title abstract 4
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000029663 wound healing Effects 0.000 title abstract 2
- 206010052428 Wound Diseases 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 2
- 239000006071 cream Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 229940100611 topical cream Drugs 0.000 abstract 1
- 229940042129 topical gel Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/488,253 US5641483A (en) | 1995-06-07 | 1995-06-07 | Wound healing formulations containing human plasma fibronectin |
PCT/CA1996/000384 WO1996040221A1 (en) | 1995-06-07 | 1996-06-06 | Wound healing formulations containing human plasma fibronectin |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE290397T1 true ATE290397T1 (de) | 2005-03-15 |
Family
ID=23938969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96917308T ATE290397T1 (de) | 1995-06-07 | 1996-06-06 | Formulierung fur die wundheilung mit menschlichem plasma fibronektin |
Country Status (8)
Country | Link |
---|---|
US (1) | US5641483A (de) |
EP (2) | EP0784481B1 (de) |
AT (1) | ATE290397T1 (de) |
CA (1) | CA2197244A1 (de) |
DE (1) | DE69634430T2 (de) |
ES (1) | ES2236733T3 (de) |
PT (1) | PT784481E (de) |
WO (1) | WO1996040221A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5583114A (en) | 1994-07-27 | 1996-12-10 | Minnesota Mining And Manufacturing Company | Adhesive sealant composition |
US6528483B2 (en) * | 1995-06-07 | 2003-03-04 | André Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
US5821220A (en) * | 1995-06-07 | 1998-10-13 | Andre Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
US7112320B1 (en) * | 1995-06-07 | 2006-09-26 | Andre Beaulieu | Solid wound healing formulations containing fibronectin |
US20030105007A1 (en) * | 1995-06-07 | 2003-06-05 | Andre Beaulieu | PDGF-betabeta and fibronectin combined in a solid wound dressing for the treatment of wounds |
US6194378B1 (en) | 1998-02-18 | 2001-02-27 | The Research Foundation Of State University Of New York | Fibronectin peptides-based extracellular matrix for wound healing |
US6497893B1 (en) | 1999-06-30 | 2002-12-24 | Kimberly-Clark Worldwide, Inc. | Silk protein treatment composition and treated substrate for transfer to skin |
CO5150202A1 (es) | 1998-12-31 | 2002-04-29 | Kimberly Clark Co | Composicion de tisu facial y metodo para usarla para el secuestro de irritantes de la piel de la secrecion nasal |
US7261881B1 (en) | 1999-05-20 | 2007-08-28 | Yale University | Modulation of angiogenesis and wound healing |
US6506394B1 (en) | 1999-06-30 | 2003-01-14 | Kimberly-Clark Worldwide, Inc. | Delivery of a botanical extract to a treated substrate for transfer to skin |
US6500443B1 (en) | 1999-06-30 | 2002-12-31 | Kimberly-Clark Worldwide, Inc. | Delivery of a sacrificial substrate to inhibit protease permeation into skin |
AU781865B2 (en) * | 1999-08-20 | 2005-06-16 | Andre Beaulieu | Solid wound healing formulations containing fibronectin |
KR100469661B1 (ko) * | 2000-03-28 | 2005-02-02 | 한스바이오메드 주식회사 | 이식용 무세포 진피층 및 이의 제조방법 |
US6503524B1 (en) | 2000-06-16 | 2003-01-07 | Kimberly-Clark Worldwide, Inc. | Delivery of a skin health benefit agent to a treated substrate for transfer to skin |
US7829072B2 (en) * | 2000-07-14 | 2010-11-09 | Carter Daniel C | Serum albumin compositions for use in cleansing or dermatological products for skin or hair |
GB0119476D0 (en) * | 2001-08-09 | 2001-10-03 | Novartis Forschungsstiftlung Z | Anti-tumour agents and method of identifying anti-tumour agents |
RU2308954C2 (ru) * | 2002-05-09 | 2007-10-27 | Медиджинез | Фармацевтическая композиция для лечения ран, содержащая плазму или сыворотку крови |
JP2004075661A (ja) * | 2002-06-18 | 2004-03-11 | Shiseido Co Ltd | 表皮基底膜ケアを特徴とする皮膚外用剤、皮膚基底膜構造形成促進剤および人工皮膚の製造方法 |
US7634668B2 (en) | 2002-08-22 | 2009-12-15 | Nvidia Corporation | Method and apparatus for adaptive power consumption |
AU2003901515A0 (en) * | 2003-04-02 | 2003-04-17 | Norika Holdings | Sterilisation process for pharmaceutical product |
US20070275874A1 (en) * | 2004-09-03 | 2007-11-29 | Yale University | Use of Leptin in Wound Healing |
US7858126B2 (en) * | 2006-08-31 | 2010-12-28 | Trinity Laboratories Inc. | Derivatives of sandalwood oil and santalols for treating cold sores and herpes |
US8700925B2 (en) | 2009-09-01 | 2014-04-15 | Nvidia Corporation | Regulating power using a fuzzy logic control system |
RU2463063C1 (ru) * | 2011-07-06 | 2012-10-10 | Федеральное государственное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова" Министерства здравоохранения и социального развития Российской Федерации | Способ получения средства для стимуляции репаративной регенерации кожного покрова |
US20130017227A1 (en) * | 2011-07-15 | 2013-01-17 | Lambert Jr Cary Jake | Wound healing compositions and associated methods |
WO2015075406A1 (en) * | 2013-11-19 | 2015-05-28 | Lipopeptide Ab | New treatment of chronic ulcers |
EP3334441B1 (de) | 2015-08-13 | 2021-06-16 | Kamada Ltd. | Aus cohn-fraktions-paste abgeleitete zusammensetzungen verwendung davon |
US10590184B2 (en) * | 2016-09-26 | 2020-03-17 | National Yang-Ming University | Process for a preparation of the modified porcine plasma fibronectin for enhance wound healing |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4455300A (en) * | 1980-03-05 | 1984-06-19 | Cutter Laboratories, Inc. | Fibronectin compositions |
US4925924A (en) * | 1984-03-27 | 1990-05-15 | University Of Medicine And Dentistry Of New Jersey | Biocompatible synthetic and collagen compositions having a dual-type porosity for treatment of wounds and pressure ulcers and therapeutic methods thereof |
JPS61103836A (ja) * | 1984-10-24 | 1986-05-22 | Green Cross Corp:The | フイブロネクチン製剤 |
US5112608A (en) * | 1987-03-13 | 1992-05-12 | Incyte Pharmaceuticals | Use of protease nexin-I to mediate wound healing |
US4837019A (en) * | 1986-08-11 | 1989-06-06 | Charles Of The Ritz Group Ltd. | Skin treatment composition and method for treating burned skin |
US4929442A (en) * | 1986-09-26 | 1990-05-29 | Exovir, Inc. | Compositions suitable for human topical application including a growth factor and/or related materials |
NZ226171A (en) * | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
US5053388A (en) * | 1987-11-09 | 1991-10-01 | Chiron Ophthalmics, Inc. | Wound healing composition and method |
JP2561113B2 (ja) * | 1988-02-16 | 1996-12-04 | 寳酒造株式会社 | 細胞接着活性ポリペプチド |
US4973466A (en) * | 1988-06-21 | 1990-11-27 | Chiron Ophthalmics, Inc. | Wound-healing dressings and methods |
US5124155A (en) * | 1988-06-21 | 1992-06-23 | Chiron Ophthalmics, Inc. | Fibronectin wound-healing dressings |
JP2561131B2 (ja) * | 1988-06-30 | 1996-12-04 | 寳酒造株式会社 | 細胞接着活性ポリペプチド |
FI86339C (fi) * | 1988-12-09 | 1992-08-10 | Ari Tuomi | Diffusionscell foer undersoekning av salvor och liknande. |
JPH04503951A (ja) * | 1988-12-20 | 1992-07-16 | ラ ホヤ キャンサー リサーチ ファウンデーション | 創傷治癒に活性のあるポリペプチド―ポリマー複合体 |
WO1990008833A1 (en) * | 1989-02-02 | 1990-08-09 | Massachusetts Institute Of Technology | Expression of recombinant fibronectin in genetically engineered cells |
GB8909916D0 (en) * | 1989-04-29 | 1989-06-14 | Delta Biotechnology Ltd | Polypeptides |
ATE92107T1 (de) * | 1989-04-29 | 1993-08-15 | Delta Biotechnology Ltd | N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen. |
US5155038A (en) * | 1990-02-22 | 1992-10-13 | W. R. Grace & Co.-Conn. | Use of thrombospondin to promote wound healing |
GB9101191D0 (en) * | 1991-01-18 | 1991-02-27 | Univ London | Wound treatment |
GB9101183D0 (en) * | 1991-01-18 | 1991-02-27 | Univ London | Depot formulations |
-
1995
- 1995-06-07 US US08/488,253 patent/US5641483A/en not_active Expired - Fee Related
-
1996
- 1996-06-06 EP EP96917308A patent/EP0784481B1/de not_active Expired - Lifetime
- 1996-06-06 ES ES96917308T patent/ES2236733T3/es not_active Expired - Lifetime
- 1996-06-06 PT PT96917308T patent/PT784481E/pt unknown
- 1996-06-06 DE DE69634430T patent/DE69634430T2/de not_active Expired - Fee Related
- 1996-06-06 EP EP05004533A patent/EP1563844A3/de not_active Withdrawn
- 1996-06-06 WO PCT/CA1996/000384 patent/WO1996040221A1/en active IP Right Grant
- 1996-06-06 CA CA002197244A patent/CA2197244A1/en not_active Abandoned
- 1996-06-06 AT AT96917308T patent/ATE290397T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1563844A3 (de) | 2007-03-14 |
EP0784481A1 (de) | 1997-07-23 |
DE69634430D1 (de) | 2005-04-14 |
EP1563844A2 (de) | 2005-08-17 |
EP0784481B1 (de) | 2005-03-09 |
ES2236733T3 (es) | 2005-07-16 |
CA2197244A1 (en) | 1996-12-19 |
PT784481E (pt) | 2005-07-29 |
US5641483A (en) | 1997-06-24 |
WO1996040221A1 (en) | 1996-12-19 |
DE69634430T2 (de) | 2006-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69634430D1 (de) | Formulierung fur die wundheilung mit menschlichem plasma fibronektin | |
FR2782269B1 (fr) | Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation | |
PT859596E (pt) | Formulacoes em gel contendo factores de crescimento | |
DE59209658D1 (de) | Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung | |
ES2058517T3 (es) | Composicion cosmetica. | |
ZA904971B (en) | Stable,cosmetically acceptable topical gel formulation and method of treatment for acne | |
ATE209032T1 (de) | Retinoid-formulierungen in porösen mikrokugeln für verringerte irritation und verbesserte stabilität | |
ES2175295T3 (es) | Uso de un poliholosido en una composicion destinada a favorecer la descamcion de la piel y su composicion. | |
AU674142B2 (en) | Use of cosmetic composition | |
DE68912195D1 (de) | Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. | |
CA2411922A1 (en) | Composition for pain mediation and apparatus and method of use thereof | |
ES2063250T3 (es) | Uso de la trombospondina para facilitar la curacion de las heridas. | |
DE3685696D1 (de) | Melatoninhaltige mittel sowie deren verwendungen. | |
ES2113222T3 (es) | Utilizacion de derivados de acido benzoico para estimular el proceso de renovacion epidermica y tratar la piel. | |
DK0951294T3 (da) | Sårhelende formuleringer indeholdende humanplasmafibronectin | |
EP0801945A3 (de) | Verwendung von Glucosiden von Ferulasäure als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen | |
BR9809351A (pt) | Tecido de bainha dérmica na cura de lesões | |
ATE182784T1 (de) | Hydrogel für die applikation von therapeutischen und/oder kosmetischen wirkstoffen an die haut | |
NZ336600A (en) | Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation | |
ATE120959T1 (de) | Wasserlösliche vitamin a-zubereitungen und deren verwendung bei der hautbehandlung. | |
DE3784738D1 (de) | Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten. | |
DE68905076D1 (de) | Pharmazeutische zusammensetzung fuer die behandlung von hautwunden. | |
DE69825322D1 (de) | Topische carbamazepin-formulierungen und deren verwendung | |
IT9048186A0 (it) | Impiego teperautico della ranitidina nella cura di ferite interessantila cute e i tessuti sottostanti | |
IL122358A0 (en) | Stable gel formulation for topical treatment of skin conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0784481 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |